Competitors taking advantage of Illumina’s addition to UEL
Subscribe to keep reading.
Sign up to stay briefed on what the Chinese government is doing, thinking, and saying.
Already a subscriber? Log in.
Chinese biotech firms are trying to gobble up market share now that US competitor Illumina is on the Unreliable Entity List (UEL).
ICYMI: The US biotech giant – the leading manufacturer of high-throughput genetic sequencers, used to sequence DNA for genome research – was added to the UEL on February...